Neurovalens, a San Diego, CA- and Belfast, Northern Ireland, UK-based healthtech startup that specializes in combining neuroscience and technology to solve health issues, secured £1.1m in funding.
Backers included both the Angel CoFund (backed by the British Business Bank) and Beltrae Partners, which joined early investor TechStart NI.
The company, which has raised £1.4M in total funding to date, will use the funds to launch its Modius device.
Co-founded in 2015 by British neuroscientists Dr. Jason McKeown and Dr. Paul McGeoch, who retain the majority shareholding, Neurovalens is launching its first product, Modius, a headset that stimulates the hypothalamus, an area of the brain associated with hunger and metabolism, simultaneously to UK and US consumers via crowd-funding website Indiegogo.
The launch is scheduled for 8th August.